Trends in utilization and costs of migraine medications, 2017–2020 von Nguyen, Jennifer L., Munshi, Kiraat, Peasah, Samuel K., Swart, Elizabeth C. S., Kohli, Monal, Henderson, Rochelle, Good, Chester B.

Volltext

Impact of the COVID-19 pandemic on new starts to oral oncology medications in the US von Neilson, Lynn, Kohli, Monal, Munshi, Kiraat D, K Peasah, Samuel, Henderson, Rochelle, Passero, Vida, Good, Chester B

Volltext

Twelve month oral contraceptive pill prescriptions: Role of policy mandates on utilization von Peasah, Samuel K., Kohli, Monal, Munshi, Kiraat D., Henderson, Rochelle, Mueller, Mark, Manolis, Chronis, Huang, Yan, Swart, Elizabeth C.S., Neilson, Lynn, Good, Chester B.

Volltext

Evolving Real-World Characteristics and Step-up Dosing Among Early Initiators of Teclistamab for Multiple Myeloma - a National All-Payer Claims Database Study von Banerjee, Rahul, Kim, Nina, Kohli, Monal, Hester, Laura, Achter, Emily, Fowler, Jessica, Umeh, Emeka, Lin, Dee, Aweh, Gideon, Gifkins, Dina, Walker, Sian, Wu, Bingcao

Volltext

POSTER: MM-613 Healthcare Resource Utilization and Costs Among Patients With Relapsed/Refractory Multiple Myeloma Treated With Chimeric Antigen Receptor-T (CAR-T) Cell Therapy von Jagannath, Sundar, Kharat, Akshay, Fu, Alex, Huo, Stephen, Kohli, Monal, Adams, Shayna, Umeh, Emeka, Foster, Miran

Volltext

MM-613 Healthcare Resource Utilization and Costs Among Patients With Relapsed/Refractory Multiple Myeloma Treated With Chimeric Antigen Receptor-T (CAR-T) Cell Therapy von Jagannath, Sundar, Kharat, Akshay, Fu, Alex, Huo, Stephen, Kohli, Monal, Adams, Shayna, Umeh, Emeka, Foster, Miran

Volltext

P-276 Healthcare resource utilization and costs among patients with relapsed/refractory multiple myeloma treated with chimeric antigen receptor-T (CAR-T) cell therapy von Jagannath, Sundar, Kharat, Akshay, Fu, Alex, Huo, Stephen, Kohli, Monal, Adams, Shayna, Umeh, Emeka, Foster, Miran

Volltext